Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Tran

Showing results (1371-1380 of 1,413) with videos related to

Pageof 142
Sort By:
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|August 14, 2025
Oral Peanut Immunotherapy With Butyrate Adjuvant (OPIA) in Children: A Randomised, Controlled TrialPeter S Hsu, Elizabeth H Barnes, Michelle Barnes, et al.
Nature Communications|February 26, 2026
Laser interstitial thermal therapy and adjuvant pembrolizumab in recurrent high-grade astrocytoma: a Phase 1/randomized Phase 2b trialJian L Campian, Son B Le, Ashley Ghiaseddin, et al.
European Journal of Cancer (Oxford, England : 1990)|September 1, 2023
Stereotactic radiosurgery and anti-PD-1 + CTLA-4 therapy, anti-PD-1 therapy, anti-CTLA-4 therapy, BRAF/MEK inhibitors, BRAF inhibitors, or conventional chemotherapy for the management of melanoma brain metastasesAmmoren E Dohm, Justyn Y Nakashima, Hruday Kalagotla, et al.
Molecular and Cellular Biology|September 2, 2004
Mutant huntingtin impairs axonal trafficking in mammalian neurons in vivo and in vitroEugenia Trushina, Roy B Dyer, John D Badger, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 4, 2021
Aging and CNS Myeloid Cell Depletion Attenuate Breast Cancer Brain MetastasisAlex Man Lai Wu, Selamawit Gossa, Ramakrishna Samala, et al.
Neuro-Oncology Advances|March 26, 2025
Phase 1 trial of hypofractionated stereotactic re-irradiation in combination with nivolumab, ipilimumab, and bevacizumab for recurrent high-grade gliomasSolmaz Sahebjam, Raju R Raval, Peter A Forsyth, et al.
The Journal of Clinical Investigation|May 15, 2023
Cardiac pericytes mediate the remodeling response to myocardial infarctionPearl Quijada, Shuin Park, Peng Zhao, et al.
American Journal of Surgery|October 3, 2019
The role of the American Society of anesthesiologists physical status classification in predicting trauma mortality and outcomesCatherine M Kuza, Kazuhide Matsushima, Wendy J Mack, et al.
Journal for Immunotherapy of Cancer|April 28, 2025
Nivolumab and stereotactic radiosurgery for patients with breast cancer brain metastases: long-term results and biomarker analysis from a non-randomized, open-label, phase Ib studyKamran A Ahmed, Younchul Kim, Sungjune Kim, et al.
The Lancet. Oncology|August 29, 2017
Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trialMichael Weller, Nicholas Butowski, David D Tran, et al.
Pageof 142

Showing results (1371-1380 of 1,413) with videos related to

Sort By:
Pageof 142
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|August 14, 2025
Oral Peanut Immunotherapy With Butyrate Adjuvant (OPIA) in Children: A Randomised, Controlled TrialPeter S Hsu, Elizabeth H Barnes, Michelle Barnes, et al.
Nature Communications|February 26, 2026
Laser interstitial thermal therapy and adjuvant pembrolizumab in recurrent high-grade astrocytoma: a Phase 1/randomized Phase 2b trialJian L Campian, Son B Le, Ashley Ghiaseddin, et al.
European Journal of Cancer (Oxford, England : 1990)|September 1, 2023
Stereotactic radiosurgery and anti-PD-1 + CTLA-4 therapy, anti-PD-1 therapy, anti-CTLA-4 therapy, BRAF/MEK inhibitors, BRAF inhibitors, or conventional chemotherapy for the management of melanoma brain metastasesAmmoren E Dohm, Justyn Y Nakashima, Hruday Kalagotla, et al.
Molecular and Cellular Biology|September 2, 2004
Mutant huntingtin impairs axonal trafficking in mammalian neurons in vivo and in vitroEugenia Trushina, Roy B Dyer, John D Badger, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 4, 2021
Aging and CNS Myeloid Cell Depletion Attenuate Breast Cancer Brain MetastasisAlex Man Lai Wu, Selamawit Gossa, Ramakrishna Samala, et al.
Neuro-Oncology Advances|March 26, 2025
Phase 1 trial of hypofractionated stereotactic re-irradiation in combination with nivolumab, ipilimumab, and bevacizumab for recurrent high-grade gliomasSolmaz Sahebjam, Raju R Raval, Peter A Forsyth, et al.
The Journal of Clinical Investigation|May 15, 2023
Cardiac pericytes mediate the remodeling response to myocardial infarctionPearl Quijada, Shuin Park, Peng Zhao, et al.
American Journal of Surgery|October 3, 2019
The role of the American Society of anesthesiologists physical status classification in predicting trauma mortality and outcomesCatherine M Kuza, Kazuhide Matsushima, Wendy J Mack, et al.
Journal for Immunotherapy of Cancer|April 28, 2025
Nivolumab and stereotactic radiosurgery for patients with breast cancer brain metastases: long-term results and biomarker analysis from a non-randomized, open-label, phase Ib studyKamran A Ahmed, Younchul Kim, Sungjune Kim, et al.
The Lancet. Oncology|August 29, 2017
Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trialMichael Weller, Nicholas Butowski, David D Tran, et al.
Pageof 142